Cargando…
Imiquimod Induces Apoptosis of Squamous Cell Carcinoma (SCC) Cells via Regulation of A20
Imiquimod, a nucleoside analogue of the imidazoquinoline family, is being used to treat various cutaneous cancers including squamous cell carcinoma (SCC). Imiquimod activates anti-tumor immunity via Toll-like receptor 7 (TLR7) in macrophage and other immune cells. Imiquimod can also affect tumor cel...
Autores principales: | Sohn, Kyung-Cheol, Li, Zheng Jun, Choi, Dae-Kyoung, Zhang, Tiejun, Lim, Jae Woo, Chang, In-Kyu, Hur, Gang Min, Im, Myung, Lee, Young, Seo, Young-Joon, Lee, Jeung-Hoon, Kim, Chang Deok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990708/ https://www.ncbi.nlm.nih.gov/pubmed/24743316 http://dx.doi.org/10.1371/journal.pone.0095337 |
Ejemplares similares
-
Roles of TLR7 in Activation of NF-κB Signaling of Keratinocytes by Imiquimod
por: Li, Zheng Jun, et al.
Publicado: (2013) -
β-Catenin Regulates the Expression of cAMP Response Element-Binding Protein 1 in Squamous Cell Carcinoma Cells
por: Kim, Soo-Yeon, et al.
Publicado: (2018) -
Antitumor Effect of Albendazole on Cutaneous Squamous Cell Carcinoma (SCC) Cells
por: Zhang, Qing-Ling, et al.
Publicado: (2019) -
Potential Role of S100A8 in Cutaneous Squamous Cell Carcinoma Differentiation
por: Shin, Jung-Min, et al.
Publicado: (2016) -
Tumor Suppressive Function of NQO1 in Cutaneous Squamous Cell Carcinoma (SCC) Cells
por: Zhang, Qing-Ling, et al.
Publicado: (2019)